Peer-Review Further Supports CLEO’s Ovarian Cancer Detection Technology
By API User
Highlights CLEO’s second peer-reviewed dataset has now been published in medical journal “Diagnostics” The study concluded that CLEO’s test: Correctly identified most cancer cases that were missed by the standard marker CA125; Eliminated the majority of “false positive” results caused by CA125 use; and Correctly identified the majority of patients with early-stage ovarian cancers. Peer … Continued